Breast Cancer

Sara Hurvitz MD FACP and Kathy D. Miller MD review and share their expert perspectives on key breast cancer findings presented at the 2017 American Society of Clinical Oncology Annual Meeting.

Share

Program Content

Activities

  • TRAIN-2: Neoadjuvant CT ± Anthracyclines in HER2+ EBC
    TRAIN-2 (BOOG 2012-03): Phase III Trial of Neoadjuvant Chemotherapy ± Anthracyclines With Dual HER2 Blockade in HER2+ EBC
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

Provided by

ProCE Banner

Supporters

AbbVie

Amgen, Inc.

AstraZeneca

Celgene

Genentech Roche Virology

Halozyme

Incyte

Merck Oncology